CX3CR1 and brain ischemia: The contradictory findings may be explained by the timing of measurement wherein reports to date assessed fractalkine/CX3CR1 expression following cerebral ischemia only up to 1 week after injury whereas our study evaluated the ischemia-induced changes in fractalkine/CX3CR1 at more than 1 month after reperfusion.